Wacker acquires Spain-based biotech firm ADL BioPharma

The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters

Tatva Chintan Pharma Chem posts Q4FY23 consolidated PAT at Rs. 16.95 Cr

Tatva Chintan Pharma Chem has reported total income of Rs. 125.35 crores during the period ended March 31, 2023

Alembic Pharmaceuticals posts Q4FY2023 consolidated PAT at Rs. 152.60 Cr

The company has reported total income of Rs. 1407.34 crores during the period ended March 31, 2023

Lupin to acquire French pharmaceutical company Medisol

The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU

Ajanta pharma posts Q4FY23 consolidated PAT at Rs. 122.25 Cr

The company has reported total income of Rs. 918.67 crores during the period ended March 31, 2023

Zydus receives final approval from the USFDA for Sucralfate Tablets USP, 1 gram

CORONA Remedies collaborates with Ferring Pharmaceuticals to commercialize maternal health & urology products in India

The collaboration between CORONA and Ferring will cater to patients across India

India is emerging as a favourable destination to conduct clinical trials: PwC-USAIC Report

Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India

Hyderabad startup’s Physiotherapy monitoring device ‘Pheezee’ receives USFDA

Pheezee is designed to assess musculoskeletal and neuromuscular health.

Nouscom reaches clinical phase II using ProBioGen’s AGE1.CR.pIX production platform

Nous-209 has been developed using the Nouscom's viral vector platform